Plasma P-tau181 levels have been shown to be significantly positively correlated with both P-tau181 and tau-PET in CSF, and it appears to be a promising tool for rapid diagnosis of cognitive impairment in patients with diabetes. The gene discussed is MAPT; the disease is Cognitive impairment.